Please use this identifier to cite or link to this item: https://dspace.iiti.ac.in/handle/123456789/3970
Title: Splicing regulator SRSF1-3 that controls somatic hypermutation of IgV genes interacts with topoisomerase 1 and AID
Authors: Kumar Singh, Amit
Tamrakar, Anubhav
Jaiswal, Ankit
Kodgire, Prashant
Keywords: activation induced cytidine deaminase;DNA topoisomerase;serine arginine rich splicing factor;serine arginine rich splicing factor 1;unclassified drug;cytidine deaminase;DNA topoisomerase;isoprotein;serine arginine rich splicing factor;amino acid sequence;animal cell;Article;B lymphocyte;carboxy terminal sequence;chicken;controlled study;cytoplasm;gene locus;genetic transcription;immunofluorescence;immunoglobulin domain;immunoglobulin gene;nonhuman;nuclear localization signal;priority journal;protein localization;protein phosphorylation;protein protein interaction;RNA recognition motif;somatic hypermutation;animal;cell line;cell nucleus;genetics;immunoglobulin class switching;immunoglobulin gene;immunology;immunoprecipitation;mouse;procedures;RNA splicing;somatic hypermutation;Amino Acid Sequence;Animals;B-Lymphocytes;Cell Line;Cell Nucleus;Chickens;Cytidine Deaminase;DNA Topoisomerases, Type I;Genes, Immunoglobulin;Immunoglobulin Class Switching;Immunoprecipitation;Mice;Protein Isoforms;RNA Splicing;Serine-Arginine Splicing Factors;Somatic Hypermutation, Immunoglobulin
Issue Date: 2019
Publisher: Elsevier Ltd
Citation: Kumar Singh, A., Tamrakar, A., Jaiswal, A., Kanayama, N., Agarwal, A., Tripathi, P., & Kodgire, P. (2019). Splicing regulator SRSF1-3 that controls somatic hypermutation of IgV genes interacts with topoisomerase 1 and AID. Molecular Immunology, 116, 63-72. doi:10.1016/j.molimm.2019.10.002
Abstract: Somatic hypermutation (SHM) of Ig genes is initiated by activation-induced cytidine deaminase (AID) and requires target gene transcription. A splice isoform of SRSF1, SRSF1-3, is necessary for AID-dependent SHM of IgV genes. Nevertheless, its exact molecular mechanism of action in SHM remains unknown. Our in silico studies show that, unlike SRSF1, SRSF1-3 lacks a strong nuclear localization domain. We show that the absence of RS domain in SRSF1-3 affects its nuclear localization, as compared to SRSF1. Consequently, SRSF1-3 is predominantly present in the cytoplasm. Remarkably, co-immunoprecipitation studies showed that SRSF1-3 interacts with Topoisomerase 1 (TOP1), a crucial regulator of SHM that assists in generating ssDNA for AID activity. Moreover, the immunofluorescence studies confirmed that SRSF1-3 and TOP1 are co-localized in the nucleus. Furthermore, Proximity Ligation Assay corroborated the direct interaction between SRSF1-3 and TOP1. An interaction between SRSF1-3 and TOP1 suggests that SRSF1-3 likely influences the TOP1 activity and consequently can aid in SHM. Accordingly, SRSF1-3 probably acts as a link between TOP1 and SHM, by spatially regulating TOP1 activity at the Ig locus. We also confirmed the interaction between SRSF1-3 and AID in chicken B-cells. Thus, SRSF1-3 shows dual-regulation of SHM, via interacting with AID as well as TOP1. © 2019 Elsevier Ltd
URI: https://doi.org/10.1016/j.molimm.2019.10.002
https://dspace.iiti.ac.in/handle/123456789/3970
ISSN: 0161-5890
Type of Material: Journal Article
Appears in Collections:Department of Biosciences and Biomedical Engineering

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetric Badge: